Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition

Cancer Research

Volumn 64, Issue 4, 2004, Pages 1242-1246

  Robey, Robert W ^a   Steadman, Kenneth ^a   Polgar, Orsolya ^a   Morisaki, Kuniaki ^a   Blayney, Margaret ^a   Mistry, Prakash ^b   Bates, Susan E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Xenova Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; 7 HYDROXYSTAUROSPORINE; BREAST CANCER RESISTANCE PROTEIN; CHLOROPHYLL; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOSPORIN A; ETOPOSIDE; FLAVOPIRIDOL; FUMITREMORGIN C; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5D3; MULTIDRUG RESISTANCE PROTEIN 1; PHEOPHORBIDE; PROBENECID; PROTEIN INHIBITOR; TARIQUIDAR; TOPOTECAN; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER RESISTANCE; CELL SURFACE; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CAMPTOTHECIN; CHLOROPHYLL; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASM PROTEINS; QUINOLINES; STAUROSPORINE; TOPOTECAN;

EID: 1242293677     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3298     Document Type: Article

References (22)

1. Gottesman, M. M., Fojo, T., and Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer, 2: 48-58, 2002.
2. Miyake, K., Mickley, L., Litman, T., Zhan, Z., Robey, R., Cristensen, B., Brangi, M., Greenberger, L., Dean, M., Fojo, T., and Bates, S. E. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res., 59: 8-13, 1999.
3. Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., and Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 95: 15665-15670, 1998.
4. Allikmets, R., Schriml, L. M., Hutchinson, A., Romano-Spica, V., and Dean, M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res., 58: 5337-5339, 1998.
5. Legrand, O., Simonin, G., Beauchamp-Nicoud, A., Zittoun, R., and Marie, J. P. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia. Blood, 94: 1046-1056, 1999.
6. Robey, R. W., Honjo, Y., van de Laar, A., Miyake, K., Regis, J. T., Litman, T., and Bates, S. E. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim. Biophys. Acta, 1512: 171-182, 2001.
7. Minderman, H., Suvannasankha, A., O'Loughlin, K. L., Scheffer, G. L., Scheper, R. J., Robey, R. W., and Baer, M. R. Flow cytometric analysis of breast cancer resistance protein expression and function. Cytometry, 48: 59-65, 2002.
8. Kawabata, S., Oka, M., Soda, H., Shiozawa, K., Nakatomi, K., Tsurutani, J., Nakamura, Y., Doi, S., Kitazaki, T., Sugahara, K., Yamada, Y., Kamihira, S., and Kohno, S. Expression and functional analyses of breast cancer resistance protein in lung cancer. Clin. Cancer Res., 9: 3052-3057, 2003.
9. Jonker, J. W., Buitelaar, M., Wagenaar, E., Van Der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plosch, T., Kuipers, F., Elferink, R. P., Rosing, H., Beijnen, J. H., and Schinkel, A. H. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA, 99: 15649-15654, 2002.
10. Robey, R. W., Honjo, Y., Morisaki, K., Nadjem, T. A., Runge, S., Risbood, M., Poruchynsky, M. S., and Bates, S. E. Mutations at amino acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br. J. Cancer, 89: 1971-1978, 2003.
11. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82: 1107-1112, 1990.
12. Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Perez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M., and Bates, S. E. Acquired mutations in the MXR1 BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res., 61: 6635-6639, 2001.
13. Ozvegy, C., Varadi, A., and Sarkadi, B. Characterization of drug transport, ATP hydrolysis and nucleotide trapping by the human ABCG2 multidrug transporter: modulation of substrate specificity by a point mutation. J. Biol. Chem., 277: 47980-47990, 2002.
14. Allen, J. D., Jackson, S. C., and Schinkel, A. H. A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for doxorubicin resistance. Cancer Res., 62: 2294-2299, 2002.
15. de Bruin, M., Miyake, K., Litman, T., Robey, R., and Bates, S. E. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. Cancer Lett., 146: 117-126, 1999.
16. Robey, R. W., Medina-Perez, W. Y., Nishiyama, K., Lahusen, T., Miyake, K., Litman, T., Senderowicz, A. M., Ross, D. D., and Bates, S. E. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (MXR/BCRP/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin. Cancer Res., 7: 145-152, 2001.
17. Bunting, K. D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells, 20: 11-20, 2002.
18. Mistry, P., Stewart, A. J., Dangerfield, W., Okiji, S., Liddle, C., Bootle, D., Plumb, J. A., Templeton, D., and Charlton, P. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Res., 61: 749-758, 2001.
19. Kruijtzer, C. M., Beijnen, J. H., Rosing, H., Ten Bokkel Huinink, W. W., Schot, M., Jewell, R. C., Paul, E. M., and Schellens, J. H. Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. J. Clin. Oncol., 20: 2943-2950, 2002.
20. Leonard, G. D., Polgar, O., and Bates, S. E. ABC transporters and inhibitors: new targets, new agents. Curr. Opin. Investig. Drugs, 3: 1652-1659, 2002.
21. Nakatomi, K., Yoshikawa, M., Oka, M., Ikegami, Y., Hayasaka, S., Sano, K., Shiozawa, K., Kawabata, S., Soda, H., Ishikawa, T., Tanabe, S., and Kohno, S. Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem. Biophys. Res. Commun., 288: 827-832, 2001.
22. Komatani, H., Kotani, H., Hara, Y., Nakagawa, R., Matsumoto, M., Arakawa, H., and Nishimura, S. Identification of breast cancer resistant protein/mitoxantrone resistance/ placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure. Cancer Res., 61: 2827-2832, 2001.